Treacher-Collins syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:861OMIM:618939Q75.4
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Treacher Collins syndrome (TCS), also known as mandibulofacial dysostosis or Franceschetti-Zwahlen-Klein syndrome, is a rare genetic disorder affecting the development of bones and other tissues of the face. It is caused by mutations in the TCOF1 gene (most commonly, accounting for approximately 78-93% of cases), POLR1C gene, or POLR1D gene, all of which play critical roles in ribosomal RNA biogenesis and craniofacial development during embryogenesis. The condition primarily affects structures derived from the first and second pharyngeal arches. Key clinical features include bilateral and symmetric downward-slanting palpebral fissures (eye openings), coloboma (notching) of the lower eyelids with sparse or absent eyelashes on the lower lids, hypoplasia (underdevelopment) of the zygomatic bones and mandible (giving the face a characteristic flattened appearance), malformation or absence of the external ears (microtia or anotia), and conductive hearing loss due to abnormalities of the middle ear ossicles and external auditory canals. Cleft palate occurs in approximately 30% of affected individuals. The severity of the condition is highly variable, even within the same family, ranging from barely noticeable facial differences to severe craniofacial anomalies that can cause life-threatening airway compromise in newborns. There is currently no cure for Treacher Collins syndrome, and management is multidisciplinary and symptom-based. Treatment typically involves a coordinated team including craniofacial surgeons, otolaryngologists, audiologists, speech therapists, orthodontists, and psychologists. Airway management is the first priority in severely affected neonates, sometimes requiring tracheostomy. Hearing aids or bone-anchored hearing devices are used to address conductive hearing loss. Surgical reconstruction of the facial bones, ears, and eyelids is often performed in stages throughout childhood and adolescence. Early intervention with speech therapy and educational support is important to optimize developmental outcomes. Genetic counseling is recommended for affected individuals and their families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormality of bone mineral densityHP:0004348Hypoplasia of the zygomatic boneHP:0010669Open biteHP:0010807Short faceHP:0011219Abnormality of the middle earHP:0000370
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Treacher-Collins syndrome.

View clinical trials →

No actively recruiting trials found for Treacher-Collins syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Treacher-Collins syndrome community →

Specialists

11 foundView all specialists →
MP
Matthew L Speltz, PhD
SEATTLE, WA
Specialist
PI on 1 active trial
CM
Carrie L Heike, MD, MS
SEATTLE, WA
Specialist
PI on 1 active trial
BB
Barbara B Biesecker
CLARKS SUMMIT, PA
Specialist
PI on 16 active trials
MP
Mark Sun, PhD
COON RAPIDS, MN
Specialist
PI on 1 active trial
YM
yasser el hadidi, mds
Specialist
PI on 1 active trial
CD
Caroline ROORYCK THAMBO, Dr
Specialist
PI on 1 active trial
CM
Carrie Heike, MD, MS
SEATTLE, WA
Specialist
PI on 1 active trial
DM
Daniela Y Tanikawa, MD
Specialist
PI on 1 active trial
AP
Azra Mehmood, PhD
Specialist
PI on 1 active trial
SP
Sheikh Riazuddin, PhD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Treacher-Collins syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Treacher-Collins syndromeForum →

No community posts yet. Be the first to share your experience with Treacher-Collins syndrome.

Start the conversation →

Latest news about Treacher-Collins syndrome

No recent news articles for Treacher-Collins syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Treacher-Collins syndrome

What is Treacher-Collins syndrome?

Treacher Collins syndrome (TCS), also known as mandibulofacial dysostosis or Franceschetti-Zwahlen-Klein syndrome, is a rare genetic disorder affecting the development of bones and other tissues of the face. It is caused by mutations in the TCOF1 gene (most commonly, accounting for approximately 78-93% of cases), POLR1C gene, or POLR1D gene, all of which play critical roles in ribosomal RNA biogenesis and craniofacial development during embryogenesis. The condition primarily affects structures derived from the first and second pharyngeal arches. Key clinical features include bilateral and sym

At what age does Treacher-Collins syndrome typically begin?

Typical onset of Treacher-Collins syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Treacher-Collins syndrome?

11 specialists and care centers treating Treacher-Collins syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.